The Readout Loud
313: Biotech layoffs, founder-focused VC, & a big pharma exit
Jul 11, 2024
Jonathan Wosen discusses biotech layoffs, while Alexis Borisy and Zach Weinberg talk about their biotech incubator Curie.Bio. The podcast also covers Pfizer's leadership change and a new side effect of the diabetes drug Ozempic.
34:52
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Biopharma layoffs impact larger companies due to patent expirations and revenue declines.
- Pfizer navigates leadership changes amidst drug development challenges and addressing side effects.
Deep dives
Layoffs Shift in Pharma Industry
Layoffs in the drug industry reflect changes in the pharma landscape, predominantly affecting established pharma companies rather than startups. Job cuts are driven by factors like patents expiring, reduced COVID revenues, and the need to maintain profit margins.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
